SCHEMBL4846128

SCHEMBL4846128

CN(C)CCOc1ccccc1C(=O)C=Cc1ccc(Cl)cc1Cl

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PTPN5 P54829 1/20 0.54
MAPT P10636 6/20 0.46
ALDH1A1 P00352 4/20 0.46
SMN1; SMN2 Q16637 3/20 0.46
POLB P06746 3/20 0.46
RAB9A P51151 2/20 0.46
NPC1 O15118 1/20 0.46
LMNA P02545 5/20 0.46
ATM Q13315 1/20 0.46
KDM4E B2RXH2 4/20 0.45
GAA P10253 2/20 0.45
MAPK1 P28482 2/20 0.45
KMT2A Q03164 6/20 0.45
L3MBTL1 Q9Y468 2/20 0.45
MAOB P27338 1/20 0.45
CYSLTR1 Q9Y271 1/20 0.44
ABCG2 Q9UNQ0 1/20 0.44
MEN1 O00255 4/20 0.43
MCL1 Q07820 2/20 0.43
PKM P14618 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849185 0.95 PTPN5 (0.53) PTPN5MAPTALDH1A1SMN1; SMN2POLB
SCHEMBL4846123 0.88 MAPT (0.52) PTPN5MAPTALDH1A1SMN1; SMN2RAB9A
SCHEMBL4856209 0.88 MAPT (0.52) PTPN5MAPTALDH1A1SMN1; SMN2RAB9A
SCHEMBL4855102 0.83 MAPT (0.51) PTPN5MAPTALDH1A1SMN1; SMN2RAB9A
SCHEMBL4849180 0.83 MAPT (0.51) PTPN5MAPTALDH1A1SMN1; SMN2RAB9A
SCHEMBL4855130 0.81 ABCB1 (0.47) MAPTALDH1A1SMN1; SMN2POLBLMNA
SCHEMBL4846156 0.80 KDM4E (0.46) PTPN5MAPTALDH1A1SMN1; SMN2POLB
SCHEMBL4846787 0.80 BCHE (0.61) MAPTALDH1A1SMN1; SMN2POLBRAB9A
SCHEMBL4849641 0.80 KDM4E (0.56) MAPTALDH1A1SMN1; SMN2POLBRAB9A
SCHEMBL25202533 0.79 BCHE (0.65) ALDH1A1SMN1; SMN2KDM4EMAOBCYSLTR1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 5 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US claimed
EP-1515940-A2 AMINOALKOXY-FUNCTIONAL CHALCONES Lica Pharmaceuticals A/S (DK) 2005-03-23 EP claimed
WO-2003097574-A2 AMINOALKOXY-FUNCTIONAL CHALCONES LICA PHARMACEUTICALS A/S (DK) 2003-11-27 WO claimed
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed